Stanford University: Obsessive-Compulsive Disorder trials
The registry lists 12 Obsessive-Compulsive Disorder studies with Stanford University as lead sponsor. 5 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 5No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)RecruitingNCT05940324Phase 2
- Study of Dextromethorphan in OCD and Related DisordersRecruitingNCT04899687Phase 2
- Neuroimaging Biomarkers for Predicting rTMS Response in OCDRecruitingNCT04286126Not applicable
- Caloric Vestibular Stimulation for Modulation of Insight in Obsessive-Compulsive Spectrum DisordersRecruitingNCT03918577Not applicable
- Efficacy of Nitrous Oxide in OCD: Pilot StudyRecruitingNCT03826693Phase 2
- Dextro-Amphetamine Versus Caffeine in Treatment-resistant OCDCompletedNCT00363298Not applicableResults posted
- Memantine Augmentation in Obsessive-Compulsive DisorderCompletedNCT00264238Phase 1/2Results posted
- ERP Plus Improv Group Therapy for OCD (IMPROVE Study)CompletedNCT06265233Not applicable
- Individualized Neuroimaging Biomarkers for Predicting rTMS Response in OCDActive, not recruitingNCT05829681Not applicable
- Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related DisordersCompletedNCT03182075Not applicable
- Understanding How Ketamine Brings About Rapid Improvement in OCDCompletedNCT02624596Phase 2
- Neural Links Between OCD and AnorexiaCompletedNCT02085057